Ozempic (Semaglutide)

Ozempic® (semaglutide) is a prescription GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes, reduce cardiovascular risks, and slow kidney disease progression. It is not a weight-loss drug, but many patients experience weight reduction as a secondary benefit.Ozempic (Semaglutide)

🌟 Product Overview

• Brand Name: Ozempic®
• Generic Name: Semaglutide
• Drug Class: GLP-1 receptor agonist (incretin mimetic)
• Form: Single-patient-use injection pen (multiple strengths), tablets also available
• Administration: Weekly subcutaneous injection or oral tablet
• Availability: Prescription only, no generic equivalent

🔑 Key Benefits

• Blood sugar control: Proven to lower HbA1c when combined with diet and exercise
• Cardiovascular protection: Reduces risk of stroke, heart attack, and cardiovascular death in patients with type 2 diabetes and heart disease
• Kidney health: Slows progression of chronic kidney disease in diabetic patients
• Weight management: May help reduce body weight, though not classified as a weight-loss drug

📊 Comparison with Other GLP-1 Agonists

⚠️ Risks & Side Effects

• Common: Nausea, vomiting, diarrhea, abdominal pain
• Serious (rare): Pancreatitis, thyroid tumors (observed in animal studies), kidney injury
• Precautions: Not recommended for patients with personal/family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2